Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines.

Tihy, M; Menzinger, S; André, R; Laffitte, E; Toutous-Trellu, L; Kaya, G

Tihy, M; Menzinger, S; André, R; Laffitte, E; Toutous-Trellu, L; Kaya, G.

Afiliação

Tihy M; Department of Clinical Pathology, University Hospital of Geneva, Geneva, Switzerland.
Menzinger S; Department of Clinical Pathology, University Hospital of Geneva, Geneva, Switzerland.
André R; Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
Laffitte E; Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
Toutous-Trellu L; Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
Kaya G; Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland.

J Eur Acad Dermatol Venereol ; 35(12): 2456-2461, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34459036

Assuntos

Vacinas contra COVID-19; COVID-19; Vacina BNT162; Humanos; RNA Mensageiro; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google